Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Immunocore Expands Senior Management

This article was originally published in Scrip

Executive Summary

Immunocore Ltd. a company focused on treating cancer, viral infections and autoimmune diseases, has appointed James Sandy chief development officer and Julian Hirst director of corporate finance. Both individuals bring over 25 years' of experience from various industries to the company, with Sandy most recently being chief development officer at Creabilis Ltd. Prior to this, he held numerous positions at Pfizer Inc., including head of EU and Asian development operations, development team leader within the gastrointestinal therapeutic area and oncology therapeutic area head, EU. Hirst was previously vice chair and head of corporate finance at Panmure Gordon, head of EU technology and a managing director at UBS and head of EU media at Morgan Stanley.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064057

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel